Tag Archives: StemCells Inc

StemCells Inc. acquired by Israeli medical device company

Posted on August 16, 2016 by christalpowell

StemCells Inc. has merged with Microbot Medical.  Recently, the company abandoned their spinal cord injury Phase 2 clinical trial called the Pathway Study. See the full article HERE

Posted in spinal cord injury research, Stem Cell Research | Tagged | Comments Off on StemCells Inc. acquired by Israeli medical device company

Pathway Study accepting potential Spinal Cord Injury volunteers for trial

Posted on March 13, 2016 by christalpowell

Researchers are currently evaluating the potential of stem cell transplantation as a treatment for many neurological disorders, including spinal cord injury (SCI). Stem cells are unique from other cells in the body: •Stem cells can self-renew (make copies of themselves) … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research | Tagged , | Comments Off on Pathway Study accepting potential Spinal Cord Injury volunteers for trial

StemCells, Inc. Announces Webcast to Discuss Interim Results From the First Cohort in Its Phase II Study in Cervical SCI

Posted on November 17, 2015 by christalpowell

StemCells, Inc. Announces Webcast to Discuss Interim Results From the First Cohort in Its Phase II Study in Cervical Spinal Cord Injury StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of … Continue reading →

Posted in Regenerative Medicine, spinal cord injury research, Stem Cell Research | Tagged | 2 Comments

StemCells Inc. moves forward with IND from the FDA

Posted on October 2, 2013 by christalpowell

StemCells Inc. announced today that the U.S. Food and Drug Administration, or FDA, has authorized the firm’s Investigational New Drug, or IND, application for clinical testing of its proprietary HuCNS-SC(R) human neural stem cells as a treatment for spinal cord … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research | Tagged | Comments Off on StemCells Inc. moves forward with IND from the FDA

StemCells, Inc.’s Spinal Cord Injury Trial Approved by Health Canada

Posted on June 4, 2013 by christalpowell

NEWARK, Jun 03, 2013 (GLOBE NEWSWIRE via COMTEX) — StemCells, Inc. today announced that Health Canada has authorized the Company to expand its Phase I/II clinical trial for chronic spinal cord injury into Canada. The Phase I/II trial, currently underway … Continue reading →

Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research | Tagged , | Comments Off on StemCells, Inc.’s Spinal Cord Injury Trial Approved by Health Canada

CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day

Posted on April 20, 2013 by christalpowell

The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day

Meet the Scientists 2013 at RIRC

Posted on April 16, 2013 by christalpowell

This years Meet the Scientists saw a great turnout of dedicated paralysis cure supporters. This forum was an open question and answer session that allowed the community to ask the researchers directly the burning questions. The exciting presentations wrapped with … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on Meet the Scientists 2013 at RIRC

What the Community Wants to Know! Aileen Anderson PhD, Stephen Huhn MD and Dr Thomas Answer Questions about StemCells Inc.

Posted on January 22, 2013 by christalpowell

These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Aileen Anderson PhD,  Stephen Huhn MD, Dr. Jonathan Thomas answer questions about the StemCells Inc. human clinical trial in Zurich.

Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research | Tagged , , , , , , , , , , , , , , , , , , , , , | Comments Off on What the Community Wants to Know! Aileen Anderson PhD, Stephen Huhn MD and Dr Thomas Answer Questions about StemCells Inc.

CDRF Board votes to assist an Irvine lab presented at Working 2 Walk 2012

Posted on December 23, 2012 by christalpowell

On the heels of last weeks announcement by the ISRT in the U.K. to fund two progressive translational chronic SCI research projects seen at Working 2 walk 2012 in California, comes an announcement this week from CDRF. Peter Wilderotter, CEO … Continue reading →

Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research | Tagged , , , , , , , , | Comments Off on CDRF Board votes to assist an Irvine lab presented at Working 2 Walk 2012

Canadian stem cell trials impeded by federal regulations, doctors say

Posted on September 19, 2012 by christalpowell

When a Swiss-based researcher announced this month he had achieved some improvement in profoundly paralyzed spinal-cord-injury patients with an injection of stem cells, he generated headlines worldwide. Dr. Armin Curt’s findings were the first evidence from actual humans — though … Continue reading →

Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research | Tagged , , , , , , , , , | 2 Comments